Who Is Ineligible for Warfarin in Atrial Fibrillation?
Lancet 374:510-511, Verheugt,F.W.A., 2009
Nail-Gun Narcolepsy
Lancet 374:238, Mokhlesi,B &Khan,M., 2009
Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009
Clinicopath Conf., Atypical Hemolytic-Uremic Syndrome
NEJM 361:389-400, Case 23-2009, 2009
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Stroke 40:2349-2355, Alsheikh-Ali,A.A.,et al, 2009
Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009
Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009
Influence of Weekend Hospital Admission on Short-Term Mortality After Intracerebral Hemorrhage
Stroke 40:2387-2392, Crowley,R.W.,et al, 2009
MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009
Differential Diagnosis of Postpartum Headaches
Rev Mex Anest 32:Suppl1 S16-S23, MacArthur,A., 2009
Intracranial Aneurysms in Childhood: 27-Year Single-Institution Experience
AJNR 30:1315-1324, Hetts,S.W.,et al, 2009
Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
AJNR 30:1371-1379, Hefzy,H.M.,et al, 2009
Neurologic Prognosis After Cardiac Arrest
NEJM 361:605-611, Young,G.B., 2009
Strokes at Time of Disease Diagnosis in a Series of 287 Patients with Biopsy-Proven Giant Cell Arteritis
Medicine 88:227-235, Gonzalez-Gay,M.A.,et al, 2009
Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009
Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009
4.5 Hours: The New Time Window for Tissue Plasminogen Activator in Stroke
Stroke 40:2266-2267, Davis,S.M. &Donnan,G.A., 2009
Statin Therapy After First Stroke Reduces 10-Year Stroke Recurrence and Improves Survival
Neurol 72:1816-1822, Milionis,H.J.,et al, 2009
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Resuscitation at Birth and Cognition at 8 Years of Age: A cohort Study
Lancet 373:1615-1622,1581, Odd,D.E.,et al, 2009
The Presentation and Clinical Course of Intracranial Developmental Venous Anomalies in Adults: A Systematic Review and Prospective, Population-Based Study
Stroke 40:1980-1985, Hon,J.M.L.,et al, 2009
Causes and Severity of Ischemic Stroke in Patients with Symptomatic Intracranial Arterial Stenosis
Stroke 40:1999-2003, Famain,B.M.,et al, 2009
Hippocampal Lesion Patterns in Acute Posterior Cerebral Artery Stroke: Clinical and MRI Findings
Stroke 40:2042-2045, Szabo,K.,et al, 2009
Stroke Unit Care Is Beneficial Both for the Patient and for the Health Service and Should Be Widely Implemented
Stroke 40:1-2, Indredavik,B., 2009
Metabolic Syndrome Clusters and the Risk of Incident Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
Stroke 40:200-205,3, Rodriguez-Colon,S.M.,et al, 2009
Potentially Preventable Strokes in High-Risk Patients with Atrial Fibrillation Who Are Not Adequately Anticoagulated
Stroke 40:235-240,5, Gladstone,D.J.,et al, 2009
Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
Stroke 40:213-220, Kettani,F.-Z.,et al, 2009
The Relationship Between Baseline Blood Pressure and Computed Tomography Findings in Acute Stroke: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
Stroke 40:41-46, Sare,G.M.,et al, 2009
Relapse Management in Multiple Sclerosis
The Neurologist 15:1-5, Thrower,B.W., 2009
Association Between Recent Sports Activity, Sports Activity in Young Adulthood, and Stroke
Stroke 40:425-431, Grau,A.J.,et al, 2009
Isolated Nodular Infarction
Stroke 40:487-491, Moon,I.S.,et al, 2009
Serial Diffusion Imaging in a Case of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
Stroke 40:e15-e17, Tzoulis,C. &Bindoff,L.A., 2009
Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009
Tularemic Meningitis in the United States
Arch Neurol 66:523-527, Hofinger,D.M.,et al, 2009
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? No
Stroke 40:1944-1945,1946, Fisher,M., 2009
Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009
Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009
Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009
Relationships Between Cerebral Perfusion and Reversibility of Acute Diffusion Lesions in DEFUSE: Insights from RADAR
Stroke 40:1692-1697, Olivot,J.-M.,et al, 2009
Combined Effect of Health Behaviours and Risk of First Ever Stroke in 20 040 Men and Women over 11 Years Follow-Up in Norfolk Cohort of European Prospective Investigation of Cancer (EPIC Norfolk): Prospective Population Study
BMJ 338:639-642, Myint,P.K.,et al, 2009
Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
NEJM 360:1729-1739, Hara,K.,et al, 2009
Genomewide Association Studies of Stroke
NEJM 360:1718-1728, Ikram,M.A.,et al, 2009
Cauda Equina Syndrome
BMJ 338:881-884, Lavy,C.,et al, 2009
Prior Antiplatelet Use Dose Not Affect Hemorrhage Growth or Outcome After ICH
Neurol 72:1397-1402,1376, Sansing,L.H.,et al, 2009
Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009